The University of Southampton
University of Southampton Institutional Repository

Success in treating mild chronic hepatitis C: different outcomes - new guidelines?

Success in treating mild chronic hepatitis C: different outcomes - new guidelines?
Success in treating mild chronic hepatitis C: different outcomes - new guidelines?
* Mild chronic hepatitis C is thought to rarely result in liver related death.
* Drug treatments for chronic hepatitis C are thought to be toxic and costly.
* The results of early treatment trials in chronic hepatitis C were disappointing.
* Existing guidelines fail to recommend antiviral treatment in mild hepatitis C.
* Improved treatment responses and recognition of non-liver related morbidity require review of treatment recommendations for mild chronic hepatitis C.
Limited knowledge of the natural history of chronic hepatitis C suggests that patients with mild histological changes on liver biopsy are at low risk of developing liver related morbidity or mortality. Patients with mild disease have been excluded from the large trials of treatment for hepatitis C and consequently guidelines recommend that they are excluded from treatment. However, as the probability of a beneficial response to treatment increases with improvements in antiviral therapy so the threshold for treatment falls. Trials reporting good responses to treatment in patients with mild disease support the case for widening access to treatment. Increasing recognition that chronic hepatitis C infection can lead to impairment of quality of life that is independent of liver histology is likely to result in more patients with mild hepatitis seeking treatment, more clinical trials that include patients with milder stages of liver disease, and greater enthusiasm for their inclusion in treatment guidelines.
0954-691X
595-597
Rosenberg, William M.C.
e9bcd469-ba64-4507-8c7f-145cd9ed2ba3
Rosenberg, William M.C.
e9bcd469-ba64-4507-8c7f-145cd9ed2ba3

Rosenberg, William M.C. (2002) Success in treating mild chronic hepatitis C: different outcomes - new guidelines? European Journal of Gastroenterology & Hepatology, 14 (6), 595-597.

Record type: Article

Abstract

* Mild chronic hepatitis C is thought to rarely result in liver related death.
* Drug treatments for chronic hepatitis C are thought to be toxic and costly.
* The results of early treatment trials in chronic hepatitis C were disappointing.
* Existing guidelines fail to recommend antiviral treatment in mild hepatitis C.
* Improved treatment responses and recognition of non-liver related morbidity require review of treatment recommendations for mild chronic hepatitis C.
Limited knowledge of the natural history of chronic hepatitis C suggests that patients with mild histological changes on liver biopsy are at low risk of developing liver related morbidity or mortality. Patients with mild disease have been excluded from the large trials of treatment for hepatitis C and consequently guidelines recommend that they are excluded from treatment. However, as the probability of a beneficial response to treatment increases with improvements in antiviral therapy so the threshold for treatment falls. Trials reporting good responses to treatment in patients with mild disease support the case for widening access to treatment. Increasing recognition that chronic hepatitis C infection can lead to impairment of quality of life that is independent of liver histology is likely to result in more patients with mild hepatitis seeking treatment, more clinical trials that include patients with milder stages of liver disease, and greater enthusiasm for their inclusion in treatment guidelines.

This record has no associated files available for download.

More information

Published date: 2002

Identifiers

Local EPrints ID: 27391
URI: http://eprints.soton.ac.uk/id/eprint/27391
ISSN: 0954-691X
PURE UUID: 6f4ecb6e-88bc-4cce-ade5-acef6d2b3706

Catalogue record

Date deposited: 27 Apr 2006
Last modified: 22 Jul 2022 20:37

Export record

Contributors

Author: William M.C. Rosenberg

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×